Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05615649 · ClinicalTrials.gov registry record · NA

Expanded Indications in the Pediatric BONEBRIDGE Population

A NA study of Hearing Loss, Conductive and Hearing Loss, Mixed, sponsored by Med-El Corporation.

Active
Registry status
NA
Development phase
36
Enrollment target
6
Study locations

NCT05615649 is a NA study of Hearing Loss, Conductive and Hearing Loss, Mixed that is active but no longer recruiting, run by Med-El Corporation. The registered enrollment target is 36 participants, below the 3,539-participant average among 4 other Hearing Loss, Conductive trials with a reported enrollment target (99% lower). The trial reports 6 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05615649, a NA study of Hearing Loss, Conductive and Hearing Loss, Mixed, is active but no longer recruiting, sponsored by Med-El Corporation.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
36 participants
Enrollment target
6
Study locations

Study Summary

This study will assess safety and efficacy of the MED-EL BONEBRIDGE Bone Conduction Implant in children under 12 years old with conductive or mixed hearing loss.

Interventions

  • DEVICE MED-EL BONEBRIDGE Bone Conduction Implant

Study Locations (6)

Colorado

  • University of Colorado Health/Children's Hospital of Colorado - Aurora

Florida

  • University of Miami - Miami

New Jersey

  • University Hospital Newark/Rutgers New Jersey Medical School - Newark

North Carolina

  • University of North Carolina - Chapel Hill

Ohio

  • The Ohio State University/Nationwide Children's Hospital - Columbus

Utah

  • University of Utah Health/Primary Children's Hospital - Salt Lake City

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2023-10-03
Est. Completion 2026-07
Phase NA

Sponsor

Med-El Corporation

14 total trials

What the Registry Record Tells You About NCT05615649

The ClinicalTrials.gov registry entry for NCT05615649 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,539-participant average among 4 other Hearing Loss, Conductive trials with a reported enrollment target (99% lower). The listed sponsor is Med-El Corporation, which has 14 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hearing Loss, Conductive appearing as the primary indexed condition, and to 1 intervention - of which MED-EL BONEBRIDGE Bone Conduction Implant is the first listed.

NCT05615649 reports 6 study locations spanning 6 distinct geographic areas - top geographies include Colorado, Florida, New Jersey.

Frequently Asked Questions

What is clinical trial NCT05615649 about?

NCT05615649 is a clinical study titled "Expanded Indications in the Pediatric BONEBRIDGE Population". This study will assess safety and efficacy of the MED-EL BONEBRIDGE Bone Conduction Implant in children under 12 years old with conductive or mixed hearing loss.

What is the current status of trial NCT05615649?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2023-10-03. Estimated completion is 2026-07.

What conditions does trial NCT05615649 study?

This clinical trial studies the following conditions: Hearing Loss, Conductive, Hearing Loss, Mixed.

What interventions are being tested in trial NCT05615649?

The interventions under investigation include: MED-EL BONEBRIDGE Bone Conduction Implant (DEVICE).

Who is sponsoring clinical trial NCT05615649?

This trial is sponsored by Med-El Corporation, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05615649 being conducted?

This trial has 6 study locations across Colorado, Florida, New Jersey, North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hearing Loss, Conductive

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.